FOR IMMEDIATE RELEASE
Contact: HHS Press Office
202-690-6343
media@hhs.gov

Statement by HHS Secretary Xavier Becerra on FDA’s Marketing Denial Orders to JUUL

Today, the U.S. Food and Drug Administration (FDA) issued marketing denial orders (MDOs) to JUUL Labs Inc. for all their products currently marketed in the U.S. As a result, JUUL must stop selling and distributing these products. In addition, those currently on the U.S. market must be removed, or the FDA may take enforcement action.

After reviewing JUUL’s applications to FDA seeking marketing authorization for their products, FDA determined that the applications lacked sufficient evidence to demonstrate that marketing of the products would be appropriate for the protection of the public health. Health and Human Services Secretary Xavier Becerra issued the following statement:

“This action by FDA reflects the agency’s steadfast commitment to carefully evaluating the science to ensure that only those products meeting its rigorous public health standards are granted marketing authorization. FDA has taken the proper steps to protect the health of all Americans.”

###
Note: All HHS press releases, fact sheets and other news materials are available at https://www.hhs.gov/news.
Like HHS on Facebook, follow HHS on Twitter @HHSgov, and sign up for HHS Email Updates.
Last revised:

Subscribe to RSS

Receive latest updates

Subscribe to our RSS

Media Inquiries

For general media inquiries, please contact media@hhs.gov.

Content created by Assistant Secretary for Public Affairs (ASPA)
Content last reviewed